J. Rodés-Cabau holds the Canadian Research Chair “Fondation Famille Jacques Larivière” for the Development of Structural Heart Disease Interventions and has received institutional research grants from Edwards Lifesciences, Medtronic and Heart Leaflet Technologies. T. Nazif is an investigator for the TriGUARD 3 US trial. The other author has no conflicts of interest to declare.
Sign in to read and download the full articleForgot your password?
Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com